Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add filters








Year range
1.
Braz. j. microbiol ; Braz. j. microbiol;48(3): 419-426, July-Sept. 2017. tab, graf
Article in English | LILACS | ID: biblio-889135

ABSTRACT

Abstract Antibodies and antibody fragments are nowadays among the most important biotechnological products, and Pichia pastoris is one of the most important vectors to produce them as well as other recombinant proteins. The conditions to effectively cultivate a P. pastoris strain previously genetically modified to produce the single-chain variable fragment anti low density lipoprotein (-) under the control of the alcohol oxidase promoter have been investigated in this study. In particular, it was evaluated if, and eventually how, the carbon source (glucose or glycerol) used in the preculture preceding cryopreservation in 20% glycerol influences both cell and antibody fragment productions either in flasks or in bioreactor. Although in flasks the volumetric productivity of the antibody fragment secreted by cells precultured, cryopreserved and reactivated in glycerol was 42.9% higher compared with cells precultured in glucose, the use of glycerol in bioreactor led to a remarkable shortening of the lag phase, thereby increasing it by no less than thrice compared to flasks. These results are quite promising in comparison with those reported in the literature for possible future industrial applications of this cultivation, taking into account that the overall process time was reduced by around 8 h.


Subject(s)
Pichia/metabolism , Industrial Microbiology/methods , Carbon/metabolism , Single-Chain Antibodies/biosynthesis , Antibodies/metabolism , Pichia/growth & development , Pichia/genetics , Recombinant Proteins/genetics , Recombinant Proteins/metabolism , Culture Media/metabolism , Culture Media/chemistry , Single-Chain Antibodies/genetics , Fermentation , Glycerol/metabolism , Lipoproteins, LDL/immunology , Antibodies/genetics
2.
São Paulo; s.n; 2010. 139 p. ilus, tab, graf.
Thesis in Portuguese | LILACS | ID: lil-566891

ABSTRACT

O ácido clavulânico (AC) é um potente inibidor de β-lactamases utilizado na área médica. Métodos alternativos, econômicos e simples para sua purificação são de grande interesse. Este trabalho objetivou produzir e extrair AC de Streptomyces spp. por fermentação extrativa utilizando sistema de duas fases aquosas (SDFA) - polietileno glicol (PEG)/sais fosfato. Foi selecionado o melhor produtor de AC entre sete linhagens de Streptomyces spp. Avaliou-se a influência de cinco fatores no cultivo do melhor produtor em frascos agitados (pH, temperatura, velocidade de agitação, concentrações das fontes de nitrogênio e de carbono), utilizando planejamento experimental estatístico. Definidas as melhores condições de cultivo, foram estudadas a produção e a extração do AC em fermentação extrativa utilizando SDFA em frascos agitados e em sistema descontínuo utilizando biorreator. Em biorreator também foram realizados o estudo termodinâmico do processo de fermentação nas condições ótimas obtidas nas etapas anteriores e a determinação do coeficiente volumétrico de transferência de massa (kLa), comparando os sistemas de fermentação no meio de cultivo simples (SF) e fermentação extrativa utilizando sistema SDFA PEG/sais fosfato (SFE) sem e com crescimento microbiano. A linhagem de Streptomyces selecionada como a melhor produtora de AC foi a DAUFPE 3060, a qual apresentou a maior produção desse inibidor, 494 mg/L em 48h, em frascos agitados nas condições: pH 6,0, 32ºC, 150 rpm, 5 g/L de glicerol e 20 g/L de farinha de soja. Após a etapa de otimização realizada para o estudo da temperatura e da concentração de farinha de soja, variáveis mais significativas no estudo de seleção, a temperatura e a concentração de farinha de soja ótimas, foram 32ºC e 40 g/L, respectivamente, com produção de 629 mg/L de AC em 48h. O estudo termodinâmico confirmou que a temperatura de 32ºC é a máxima de produção do AC; após esse valor, inicia-se, gradualmente, a degradação do AC...


Clavulanic acid (CA) is a potent inhibitor of β-lactamases used in the medical field. Alternative methods, economic and simple purification are of great interest. This PhD project aims to produce and extract clavulanic acid of Streptomyces spp. By extractive fermentation using aqueous two-phase system (ATPS) - Polyethylene glycol (PEG)/phosphate salts. The best producer of clavulanic acid among seven strains of Streptomyces spp was selected. The influence of five factors in the cultivation of the best producer in flasks (pH, temperature, agitation velocity, concentrations of nitrogen and carbon sources) using statistical experimental design was evaluated. Defined the best cultivation conditions, the production and extraction of clavulanic acid by extractive fermentation using ATPS in flasks and in a batch system using a bioreactor was analyzed. In batch system using a bioreactor were also carried out the thermodynamic study of the fermentation process in optimum conditions determined in previous steps and also determined the volumetric mass transfer coefficient (kLa) comparing the fermentation systems in simple culture medium (SF) and in a extractive fermentation using aqueous two-phase system (ATPS) PEG/phosphate salts (SEF) medium with and without microbial growth. A strain of Streptomyces spp. selected as the best producer of AC was DAUFPE 3060, which showed the highest production of this inhibitor, 494 mg/L at 48h, in flasks under the conditions of pH 6.0, 32 ºC, 150 rpm, 5 g/L of glycerol and 20 g/L of soybean flour. After the optimization step, the most significant variables in the study selection, temperature and concentration of soybean flour, were studied. The optimal values were 32 ºC and 40 g/L of temperature and soybean flour concentration, respectively, with production of 629 mg/L of CA after 48h of cultivation. The thermodynamic study confirmed that 32 ºC is the maximum temperature production of CA, after this value, starts…


Subject(s)
Clavulanic Acid , Fermentation , Streptomyces , Biochemistry , Drug Industry , Industrial Microbiology , Technology, Pharmaceutical/methods
SELECTION OF CITATIONS
SEARCH DETAIL